Kymera extends growth with $2.1B Sanofi deal

French drug giant Sanofi has evolved from one of Kymera Therapeutics Inc.’s investors to a development partner.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.